BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options

Impact · against what's priced in

BDX gains a modest catalyst from the U.S. launch of the Liverty TIPS Stent Graft, which leverages existing European success to enter a new market. The availability of proprietary clinical data for small-diameter stents provides a competitive advantage that should drive incremental revenue in the Interventional segment.

BDX+0.50

No priced-in read yet